The Asia Pacific IC device market will continue to grow rapidly, driven by the increasing prevalence and diagnosis of CAD among the patient population. Rising uptake of next-generation coronary stents later in the forecast period, increasing PCI volumes, and the recent increase of the price ceiling for coronary stents in the large Indian market will all contribute to overall expansion through 2028.
This Medtech 360 Report provides high-level market metrics for IC devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.
- Interventional Cardiology Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Sangeetha Iyer, Pharm.D
Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG